Found 4,563 investors

Sylvie Ganter

United States

Mr. Jim Waltrip served as Chief Technology Officer at Mordernize. Previously, he co-founded All Web Leads and served as itsChief Visionary Officer. He, along with Ryan Patterson, founded the company in 2005 after identifying the opportunity for a new, technology-driven approach to lead generation for the insurance industry. His technical background includes development of complex device management software, working with highly multi-threaded systems and distributed control architectures with complex timing dependencies. Prior to All Web Leads, Mr. Waltrip has held technical development and technology management positions at companies including High End Systems and Broadjump (Motive).
Individual/Angel Seed

Past Investments

nextProtein

Taylor Clauson

United States

Dr. Kevin O'Hara served as Board Member at Fippex. Kevin is an Adjunct Professor at Northwestern University Law School, Chairman of the Kevin J. P. O'Hara Family (Charitable) Foundation, and a private equity and real estate investor. He sits on several boards of directors and boards of trustees, including ITG (NYSE listed: ITG) and Pivot Point Consulting, and is a member of the advisory board of Quadriserv, Inc. Mr. O'Hara was CEO of the Trading/Exchanges Division of the Gulf Finance House (Bahrain/UAE) in 2008-2009. He served as the Chief Administrative Officer and Chief Strategy Officer of CBOT (Chicago Board of Trade) Holdings, Inc. in 2006-07. (CBOT was acquired by CME in 2007.) He was employee no. 11 and served as Chief Administrative Officer, General Counsel and Corporate Secretary of Archipelago Holdings, Inc., from 1999 to 2006; and served as Executive Vice President and Co-General Counsel of NYSE Group, Inc. in 2006. (Archipelago was acquired by NYSE in 2006.) Mr. O'Hara worked in Romania and Lithuania from 1995 to 1999 on capital market development for the consulting firms Financial Markets International and Pragma Corporation. He worked as a civil prosecutor in the Division of Enforcement of the U.S. Securities and Exchange Commission during 1991-1995 and as Special Assistant United States Attorney at the U.S. Department of Justice. From 1988 to 1991, he practiced law at the Chicago firm of (McGuire Woods) Ross & Hardies. Mr. O'Hara earned a J.D. from Georgetown University Law Center and B.A. from the University of Chicago.
Individual/Angel Seed Pre-Seed

Past Investments

Leap2, SmartHome Ventures, AgLocal, GreenLight Connectivity Solutions, Zubie, Mobile Intelligence Solutions, Zave Networks, eRecyclingCorps, InSequent

Teddy Sagi

Italy

Dr. Miuccia Prada serves as Co-Chief Executive Officer & Lead Creative Director at Prada. She Prada holds a directorships in Prada Holding S.p.A., Bellatrix S.p.A. and Ludo S.r.l., which are substantial shareholders of the Company. Ms. Prada received an Honorary Doctorate from the Royal College of Art (London) in 2000. Ms. Prada is a co-founder of our Group along with Mr. Bertelli. Ms. Prada is not and has not been a director of any other listed companies in Hong Kong or overseas in the past three years. She is also an Angel Investor.
Individual/Angel

Past Investments

ActiView, SmartGreen

Teodor Bjerrang

United States

Mr. Shahram Bonyadlou is an Angel Investor. Dr. Bonyadlou completed his residency and fellowship at the Keck Medical Center of USC. He was awarded the Roentgen Resident/Fellow Award for his research while in training. Upon completion of his training, Dr. Bonyadlou joined the staff at USC as assistant professor of radiology. His research activities in nuclear medicine have produced many abstracts, presentations, book chapters. He is currently the principal investigator for several groundbreaking research projects including PET myocardial perfusion scintigraphy, utilizing novel F18-Flurpiridaz and largest Parkinson imaging study (DAT Scan) through Michael J Fox Foundation. He is also actively involved in new treatment modalities including SirSphere, Lutathera, and Illumet. Dr. Bonyadlou has recently completed his MBA at US Marshall School of Business and is actively involved in radiology department operations. He is an active member of several committees. He values education and is dedicated to training future radiologists.
Individual/Angel

Past Investments

Ignite Procurement, Be Your Best, Memory, Timely, Inzpire.me, Confrere, Tribe Insurance, PortalOne, Inc

Terry Dougas

China

Ms. Xin Zhang is a Co-Founder, Co-Owner and serves as Chief Executive Officer of SOHO China. As CEO, she has led the company to become the largest developer of prime office real estate in China. After working in investment banking for Goldman Sachs and Travelers Group, she returned to Beijing to co-found SOHO China. Featured repeatedly as an opinion leader on China's real estate market and economic development, her triumphant entrepreneurship and personal story have led her to be recognized internationally as an emblem of China's growth and domestically as a celebrity figure with over 9 million followers on "Weibo", the Chinese version of "Twitter". She also serves as an Advisory Member at The Breakthrough Energy Coalition. She is also an Angel Investor.
Individual/Angel Seed Pre-Seed

Past Investments

SharePractice, HOOKED, 1821 Media, Pop Suki, HQ Trivia, Instamotor, Contraline, Escher Reality, Niantic, Xperiel, STYLEBEE, Abra, Roadster, Bunch, YourMechanic, Stan Lees Kids Universe, Fixed, toonstar, Wuu, Bitski, VidMob, ZenBusiness, Leaftail Labs, vidIQ, MASSLESS, Mira Labs, 1821 Comics, Gather in real life

Terry McBride

Vancouver, British Columbia, Canada

Terry McBride is the current CEO and one of three founders of the Nettwerk Music Group, which includes Nettwerk Productions (CanadaвАЩs larges...
Individual/Angel Seed

Past Investments

Nettwerk Music Group

Thomas Bernik

United States

Mr. Michael Bates is an Angel Investor. Mr. Bates served as Director at Dextera Surgical. Mr. Bates served as Board Member at Deep Blue Medical Advances. He was an Advisor of ShareVault. He also is an Angel Investor. Bates serves as an Advisor at Pandesa. Most recently, he was Chief Financial Officer for St. Francis Medical Technologies, acquired by Kyphon Inc. in January 2007 for approximately $725 million. In addition to the St. Francis success, he has contributed to successful investor outcomes in his three previous companies. He served as Vice President of Finance and Administration and CFO for Silicon Genetics, acquired by Agilent Technologies; Collagen Aesthetics, Inc., acquired by Inamed Corporation; and Penederm Incorporated, a publicly-traded specialty pharmaceutical company, acquired by Mylan Laboratories. He is a certified public accountant, having begun his career at Deloitte and Touche LLP. He is a graduate of California State University at Hayward and received an MBA in Finance from the University of California at Berkeley.
Individual/Angel

Past Investments

UMT, Ticketbis, Bluesmart, Home61, sapaso, LiveRate, WeHostels, DeckDAQ

Thomas Bodenski

New York, New York, United States

For the last 22 years I’ve built my career simplifying work and personal life through the use of technology. I am currently invested and...
Individual/Angel Seed

Past Investments

Yuggler

Thomas Hillman

United States

Mr. David Rubenstein is the Founder of Declaration Capital. He is a Co-Founder and serves as Co-Executive Chairman and Board Member at The Carlyle Group. He also serves as the Board Member at Breakthrough Energy Ventures. Previously, Mr. Rubenstein served as Co-Chief Executive Officer of Carlyle. Mr. Rubenstein also serves on Carlyle's Executive Group. Prior to forming Carlyle in 1987, Mr. Rubenstein practiced law in Washington, D.C. with Shaw, Pittman, Potts & Trowbridge LLP (now Pillsbury Winthrop Shaw Pittman LLP). From 1977 to 1981 Mr. Rubenstein was Deputy Assistant to the President for Domestic Policy. From 1975 to 1976, he served as Chief Counsel to the U.S. Senate Judiciary Committee's Subcommittee on Constitutional Amendments. From 1973 to 1975, Mr. Rubenstein practiced law in New York with Paul, Weiss, Rifkind, Wharton & Garrison LLP. Among other philanthropic endeavors, Mr. Rubenstein is Chairman of the Board of Trustees of the John F. Kennedy Center for the Performing Arts and the Council on Foreign Relations and serves as Chairman of the Board of Trustees at The National Gallery of Art, Johns Hopkins Medicine, University of Chicago, Memorial Sloan-Kettering Cancer Center, the Lincoln Center for the Performing Arts, the Institute for Advanced Study, the Brookings Institution and the World Economic Forum. Mr. Rubenstein serves as a Fellow of the Harvard Corporation and as President of the Economic Club of Washington. Mr. Rubenstein is a member of the American Academy of Arts and Sciences, Business Council, Chairman of the Harvard Global Advisory Council, Chairman of the Madison Council of the Library of Congress, a member of the Board of Dean's Advisors of the Business School at Harvard, a member of the Advisory Board of the School of Economics and Management at Tsinghua University, and Board of the World Economic Forum Global Shapers Community. Mr. Rubenstein is a magna cum laude graduate of Duke University, where he was elected Phi Beta Kappa. Following Duke, Mr. Rubenstein graduated from The University of Chicago Law School, where he was an editor of The Law Review.
Individual/Angel

Past Investments

Rantizo

Thomas J. Fogarty

Mountain View, California, United States

Thomas J. Fogarty is an internationally recognized cardiovascular surgeon, inventor, entrepreneur and investor. Throughout his career, he ha...
Individual/Angel Seed

Past Investments

Vascular Architects

Thomas Lehrman

New York, New York, United States

Thomas D. Lehrman is the Board Director at Gerson Lehrman Group.He is a Co - Founder and former Co - Chief Executive Officer of Gerson Lehrm...
Investment Partner Individual/Angel Seed

Past Investments

Abacum, Betterment, User Interviews, EverTrue, KidPass, AirPR, Atlas Obscura, SeatGeek, Able Lending, ExecOnline, Literati, Floored, Knotable, The Muse, Academia, ZOZI, Qualified, Second Measure, Zocdoc, Directr, Voro, Factual, SidelineSwap

Tilman Ehrbeck

Washington, District of Columbia, United States

Tilman Ehrbeck draws on a deep understanding of the intersection of business, government policy, and movement building in his role as a part...
Individual/Angel Seed

Past Investments

Flexing It™

Tim Curran

Boston, Massachusetts, United States

Tim has 30 years of experience building and running software companies, beginning as a software developer and progressing through roles in i...
Individual/Angel

Past Investments

ARCBAZAR, Powerhouse Dynamics, SyncOnSet Technologies, Bluetrainio, Chatbooks, Disruptor Beam, ezCater, Frame Media, Vela Systems, Crayon, Salesjunctioncom, Coastal Village Development, instaFreebie by Libboo, Windshield, Building Engines, Promoboxx

Tim O'Connor

Canada

Mr. Zack Christensen serves as Corporate Controller & Chief Accounting Officer, US Region at Canadian Imperial Bank of Commerce. He served as Managing Director & Associate General Counsel at The Private Bank. He is an Angel Investor. Prior to this, he served as a Partner at Barack Ferrazzano Kirschbaum & Nagelberg.
Individual/Angel Seed

Past Investments

Plethora

Tobias Peggs

New York, New York, United States

Brit in NYC. Strengthening communities through #realfood as @squarerootsgrow CEO. Previously. @Aviary CEO (acquired by Adobe); @OneRiot CEO ...
Individual/Angel Seed

Past Investments

Diem, UniqueSound

Todd Boyman

United States

Pamela G. Marrone, Ph.D. is our founder and has served as our Chief Executive Officer and a member of our board of directors since our inception in 2006, as well as serving as our President from inception through January 2015 and from September 2015 to August 2017. Prior to founding the Company, in 1995 Dr. Marrone founded AgraQuest, Inc. (acquired by Bayer), where she served as chief executive officer until May 2004 and as President or Chairman from such time until March 2006, and where she led teams that discovered and commercialized several bio-based pest management products. She served as founding president and business unit head for Entotech, Inc., a biopesticide subsidiary of Denmark-based Novo Nordisk A/S (acquired by Abbott Laboratories), from 1990 to 1995, and held various positions at the Monsanto Company from 1983 until 1990, where she led the Insect Biology Group, which was involved in pioneering projects in transgenic crops, natural products and microbial pesticides. Dr. Marrone is an author of over a dozen invited publications, is in demand as a speaker and has served on the boards and advisory councils of numerous professional and academic organizations. In 2016, Dr. Marrone was elected to the Cornell University Board of Trustees. In 2013, Dr. Marrone was named the Sacramento region's Executive of the Year by the Sacramento Business Journal and Cleantech Innovator of the Year by the Sacramento Area Regional Technology Alliance and Best Manager with Strategic Vision by Agrow in 2014. Dr. Marrone earned a B.S. in Entomology from Cornell University and a Ph.D. in Entomology from North Carolina State University. We believe Dr. Marrone's qualifications to sit on our board of directors include the fact that, as our founder, Dr. Marrone is uniquely familiar with the business, structure, culture and history of our company and that she also brings to the board of directors considerable expertise based on her management and technical and commercialization experience in the biopesticide industry. On December 2, 2019, Marrone Bio Innovations, Inc. reported that Dr. Pamela Marrone has announced her intention to retire from her position as the Company's Chief Executive Officer and an employee of the Company effective immediately prior to the date on which a new CEO is retained, after which Dr. Marrone will continue to serve on the Company's board of directors as a non-executive member. On July 6, 2020, Ms. Pamela G. Marrone willstep down from position of CEO effective 1st August 2020 and continue as director.
Individual/Angel

Past Investments

Hungry Planet

Tohru Akaura

Tokyo, Tokyo, Japan

1991 Tokai University Department of Control Engineering graduation. Japan Associated Finance Co., Ltd. in 1991 (now: JAFCO Co., Ltd.) joined...
Investment Partner

Past Investments

AgroDesign Studio, UUUO, TERASS, Retrocausal, park & ​​port Co., Ltd., Linc'well, METRICA Japan, Cerby, CUICIN, Leaner Technologies, PostCoffee, Olly Smart Credit Card, Arena.im, M&A Cloud, TENTIAL, Axel Mark, Parame, EmbodyMe, IMCF, Enowa Japan, INNOVIA Japan, yup, Timebank, Ispace Technologies, iCARE, SATORI Inc., minacolor, IoTBASE, PlaceHolder, Let, AI Medical Service, PoliPoli, Shopkirana, SAKELOGY, Legmin, AGRIST, Pale Blue, Space BD, Yulu, TRIDENT Japan, Pretia, ALDOCK, Future Standard, Fez Japan, Meleap, Plum, KiteRa, GamingMonk, CloudNatix, Crezit, Saleshub Japan, teTra aviation, Thirdverse, Catallaxy, bellFace, Rehab for JAPAN, ReadHub, Pixie Dust Technologies, Farmally, chikaku, Joyz, Inc., WaveOne, TownWiFi, Payme Japan, Ax Robotix, Panair, TYFFON, NeuraLegion, Crosshare, Tripeur, Co-LABO MAKER, AVA Intelligence, Kobster, Robot Fund, WED, Wellness, StayAbode, Graffer, Skillate

Tom Christopoul

New City, New York, United States

Tom Christopoul - Executive Vice President and Co-Founder @ 54 Madison Partners
Individual/Angel Seed

Past Investments

ZOZI, BoxMedia

Tom Dare

Santa Monica, California, United States

Tom has over 20 years of experience building and managing Internet companies through startup, growth, funding, and exit stages. Tom is the c...
Individual/Angel Seed

Past Investments

MeUndies

Tom Drummond

United States

Mr. Richard Ditizio serves as President & Chief Operating Officer at Milken Institute. He is an Angel Investor. He joined the Institute after a 25-year career in banking. He most recently served as CEO of Citi Private Bank, a 1,100-employee unit of Citigroup. Prior to that, Ditizio ran the North American UHNW practice for the bank, leading 24 offices across the U.S. and Canada. In these roles, he counseled clients across a continuum of issues, including business succession, philanthropy, and raising children amid affluence. His work with UHNW families has been widely profiled in such media outlets as the Wall Street Journal, Financial Times, Lifestyles, CNBC, and Reuters; he has been the featured speaker at engagements for the Jewish Funders Network, Tiger 21, and others. A recipient of the NSFRE Corporate Executive award, Ditizio has been involved with numerous nonprofit boards and charitable organizations throughout his career.
Individual/Angel Seed Pre-Seed

Past Investments

CircleCI, Martini Media Network, Healthline Media, Netli, Kloudless, Fingerprint, Struq, Docracy, Palantir Technologies, Activate Networks, Blockdaemon, Intelligize, Pusher, SpaceCurve, Snyk, Babylon
Showing 981 to 1000 of 4,563 results